Current concepts in primary effusion lymphoma and other effusion-based lymphomas

Korean Journal of Pathology

Volumn 48, Issue 2, 2014, Pages 81-90

  Kim, Yoonjung ^a   Park, Chan Jeong ^b   Roh, Jin ^b   Huh, Jooryung ^b  

^a Veterans Health Service Medical Center   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Human herpes virus 8; Lymphoma, primary effusion

Indexed keywords

EID: 84899629205     PISSN: 17381843     EISSN: None     Source Type: Journal    
DOI: 10.4132/KoreanJPathol.2014.48.2.81     Document Type: Review

References (48)

1. Said J, Cesarman E. Primary effusion lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press, 2008; 260-1.
2. Said J. Hematopathology of human Immunodeficiency virus (HIV) infection. In: Jaffe ES, Harris NL, Vardiman JW, Campo E, Arber DA, eds. Hematopathology. Philadelphia: Elsevier Saunders, 2011; 867-83.
3. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995; 332: 1186-91.
4. Chadburn A, Hyjek E, Mathew S, Cesarman E, Said J, Knowles DM. KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma. Am J Surg Pathol 2004; 28: 1401-16.
5. Cesarman E. Gammaherpesvirus and lymphoproliferative disor ders in immunocompromised patients. Cancer Lett 2011; 305: 163-74.
6. Petitjean B, Jardin F, Joly B, et al. Pyothorax-associated lymphoma: a peculiar clinicopathologic entity derived from B cells at late stage of differentiation and with occasional aberrant dual B- and T-cell phenotype. Am J Surg Pathol 2002; 26: 724-32.
7. Ohsawa M, Tomita Y, Kanno H, et al. Role of Epstein-Barr virus in pleural lymphomagenesis. Mod Pathol 1995; 8: 848-53.
8. Ichinohasama R, Miura I, Kobayashi N, et al. Herpes virus type 8-negative primary effusion lymphoma associated with PAX-5 gene rearrangement and hepatitis C virus: a case report and review of the literature. Am J Surg Pathol 1998; 22: 1528-37.
9. Alexanian S, Said J, Lones M, Pullarkat ST. KSHV/HHV8-negative effusion-based lymphoma, a distinct entity associated with fluid overload states. Am J Surg Pathol 2013; 37: 241-9.
10. Ha SY, Choi YL, Kim SJ, Ko YH. Diffuse large B-cell lymphoma associated with chronic inflammation manifested as a soft tissue mass: incidental discovery on histological examination. Korean J Pathol 2011; 45: 417-22.
11. Yoon SO, Suh C, Lee DH, et al. Distribution of lymphoid neoplasms in the Republic of Korea: analysis of 5,318 cases according to the World Health Organization classification. Am J Hematol 2010; 85: 760-4.
12. Kim JM, Ko YH, Lee SS, et al. WHO classification of malignant lymphomas in Korea: report of the third nationwide study. Korean J Pathol 2011; 45: 254-60.
13. Ariza-Heredia EJ, Razonable RR. Human herpes virus 8 in solid organ transplantation. Transplantation 2011; 92: 837-44.
14. Moore PS, Chang Y. Molecular virology of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci 2001; 356: 499-516.
15. de Sanjose S, Mbisa G, Perez-Alvarez S, et al. Geographic variation in the prevalence of Kaposi sarcoma-associated herpesvirus and risk factors for transmission. J Infect Dis 2009; 199: 1449-56.
16. Han TH, Chung JY, Kim SW. Seroprevalence of human herpesvirus 8 in children in Seoul, Korea. Pediatr Infect Dis J 2005; 24: 476.
17. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996; 348: 858-61.
18. Jenkins FJ, Hoffman LJ, Liegey-Dougall A. Reactivation of and primary infection with human herpesvirus 8 among solid-organ transplant recipients. J Infect Dis 2002; 185: 1238-43.
19. Edelman DC. Human herpesvirus 8: a novel human pathogen. Virol J 2005; 2: 78.
20. Ganem D. KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J Clin Invest 2010; 120: 939-49.
21. Gantt S, Casper C. Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment. Curr Opin Infect Dis 2011; 24: 295-301.
22. Carbone A, Gloghini A. AIDS-related lymphomas: from pathogenesis to pathology. Br J Haematol 2005; 130: 662-70.
23. Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996; 88: 645-56.
24. Ansari MQ, Dawson DB, Nador R, et al. Primary body cavity-based AIDS-related lymphomas. Am J Clin Pathol 1996; 105: 221-9.
25. Deloose ST, Smit LA, Pals FT, Kersten MJ, van Noesel CJ, Pals ST. High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma. Leukemia 2005; 19: 851-5.
26. Pan ZG, Zhang QY, Lu ZB, et al. Extracavitary KSHV-associated large B-Cell lymphoma: a distinct entity or a subtype of primary effusion lymphoma? Study of 9 cases and review of an additional 43 cases. Am J Surg Pathol 2012; 36: 1129-40.
27. Patel S, Xiao P. Primary effusion lymphoma. Arch Pathol Lab Med 2013; 137: 1152-4.
28. Carbone A, Gloghini A, Larocca LM, et al. Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. Blood 2001; 97: 744-51.
29. Vega F. Primary effusion lymphoma (PEL) and solid variant of PEL. In: Medeiros LJ, Miranda RN, Wang SA, eds. Diagnostic pathology: lymph nodes and spleen with extranodal lymphomas. Altona: Amirsys, 2011; 7. 78-85.
30. Coupland SE, Charlotte F, Mansour G, Maloum K, Hummel M, Stein H. HHV-8-associated T-cell lymphoma in a lymph node with concurrent peritoneal effusion in an HIV-positive man. Am J Surg Pathol 2005; 29: 647-52.
31. Klein U, Gloghini A, Gaidano G, et al. Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. Blood 2003; 101: 4115-21.
32. Ferry JA. Extramodal lymphomas. Philadelphia: Saunders-Elsevier, 2011; 81-132.
33. Kang SY, Park CJ, Huh JR, Kang YG, Lee YS, Chi HS. Three cases of primary effusion lymphoma. Korean J Hematol 2003; 38: 136-41.
34. Kim YA, Huh J, Yoon SO, et al. Primary effusion lymphoma and human herpesvirus 8-negative effusion-based lymphoma: analysis of 17 cases in Korea. Korean J Pathol 2013; 47 Suppl 1: S100.
35. Chan JK, Aozasa K, Gaulard P. DLBCL associated with chronic inflammation. In: Swerdlow SH, Campo E, Harris NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid ders in immunocompromised patients. Cancer Lett 2011; 305: 163-74.
36. Stein H, Harris NL, Campo E. Plasmablastic lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press, 2008; 256-7.
37. Lee HI, Koo HR, Han EM, et al. Fine needle aspiration cytology of the plasmablastic lymphoma in human immunodeficiency virus (HIV) negative patient: a case report. Korean J Cytopathol 2005; 16: 47-51.
38. Delsol G, Falini B, Muller-Hermelink HK, et al. Anaplastic large cell lymphoma (ALCL), ALK-positive. In: Swerdlow SH, Campo E, Harris NL, et al., eds. WHO cclassification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press, 2008; 312-6.
39. McKenna RW, Kyle RA, Kuehl WM, Grogan TM, Harris NL, Coupland RW. Plasma cell neoplasms. In: Swerdlow SH, Campo E, Harris NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press, 2008; 200-13.
40. Vega F, Chang CC, Medeiros LJ, et al. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol 2005; 18: 806-15.
41. Kim Y, Leventaki V, Bhaijee F, Jackson CC, Medeiros LJ, Vega F. Extracavitary/solid variant of primary effusion lymphoma. Ann Diagn Pathol 2012; 16: 441-6.
42. Delsol G, Campo E, Gascoyne RD. ALK-positive large B-cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press, 2008; 254-5.
43. Isaacson PG, Campo E, Harris NL. Large B-cell lymphoma arising in HHV8-associated multicentric Castleman diseae. In: Swerdlow SH, Campo E, Harris NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press, 2008; 258-9.
44. Ohori NP, Whisnant RE, Nalesnik MA, Swerdlow SH. Primary pleural effusion posttransplant lymphoproliferative disorder: Distinction from secondary involvement and effusion lymphoma. Diagn Cytopathol 2001; 25: 50-3.
45. Lechapt-Zalcman E, Rieux C, Cordonnier C, Desvaux D. Posttransplantation lymphoproliferative disorder mimicking a nonspecific lymphocytic pleural effusion in a bone marrow transplant recipient. A case report. Acta Cytol 1999; 43: 239-42.
46. Ripamonti D, Marini B, Rambaldi A, Suter F. Treatment of primary effusion lymphoma with highly active antiviral therapy in the setting of HIV infection. AIDS 2008; 22: 1236-7.
47. Siddiqi T, Joyce RM. A case of HIV-negative primary effusion lymphoma treated with bortezomib, pegylated liposomal doxorubicin, and rituximab. Clin Lymphoma Myeloma 2008; 8: 300-4.
48. Ghosh SK, Wood C, Boise LH, et al. Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa B. Blood 2003; 101: 2321-7.